[Delayed-type hypersensitivity skin test with modified autologous lymphocytes in the diagnosis and monitoring of patients with lung cancer].
The delayed-type hypersensitivity skin test was run with autologous modified lymphocytes, treated with phytohemagglunin, in 218 patients suffering different lung diseases. The three following groups were identified: lung cancer, chronic non-specific disease of the lung and benign lesions in the lung. Cancer patients proved positive to autologous modified lumphocytes in 90.4%. Skin reaction was close to normal in the other groups. Skin reaction dynamics was compared in cases of recurrence and recurrence-free patients in the group of surgical treatment for lung cancer.
Bakhlaev
I E
IE
Erkhov
V S
VS
Ageenko
A I
AI
Oleĭnik
E K
EK
Trakhtenberg
A K
AK
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000276:immunology / Q000601:surgery; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D010835:Phytohemagglutinins; D012882:Skin Tests / Q000379:methods*; D013997:Time Factors
D010835:Phytohemagglutinins